Profil
Ms. Michelle Corral is a President & Director at Mason General Hospital and a VP-Investor Relations & Communications at Tenaya Therapeutics, Inc. She is on the Board of Directors at Mason General Hospital.
Ms. Corral was previously employed as a VP-Communications & Investor Relations by Alector, Inc., a Senior Director-Corporate Communications & IR by MyoKardia, Inc., and a Senior Director-Corporate Communications by Mereo BioPharma 5, Inc.
Postes actifs de Michelle Corral
| Sociétés | Poste | Début |
|---|---|---|
| TENAYA THERAPEUTICS, INC. | Investor Relations Contact | - |
Mason General Hospital
Mason General Hospital Hospital/Nursing ManagementHealth Services Owns and operates hospital | President | - |
Anciens postes connus de Michelle Corral
| Sociétés | Poste | Fin |
|---|---|---|
| ALECTOR, INC. | Investor Relations Contact | 01/04/2022 |
| MYOKARDIA, INC. | Investor Relations Contact | 01/02/2021 |
| ONCOMED PHARMACEUTICALS INC | Investor Relations Contact | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Mereo BioPharma 5, Inc.
Mereo BioPharma 5, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer stem cell therapeutics | Health Technology |
MyoKardia, Inc.
MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
Mason General Hospital
Mason General Hospital Hospital/Nursing ManagementHealth Services Owns and operates hospital | Health Services |
Alector, Inc.
Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
Tenaya Therapeutics, Inc.
Tenaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for heart failure | Health Technology |
















